Screening Novel Agent Combinations to Expedite CTCL Therapeutic Development-Reference-Cited by-同舟云学术

Screening Novel Agent Combinations to Expedite CTCL Therapeutic Development

Published:2021-01 Issue:1 Volume:141 Page:217-221
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Mirza Fatima N.^ORCID,Yumeen Sara^ORCID,Lewis Julia M.^ORCID,King Amber Loren O.^ORCID,Kim Sa Rang^ORCID,Carlson Kacie R.^ORCID,Umlauf Sheila^ORCID,Surovtseva Yulia V.^ORCID,Foss Francine M.^ORCID,Girardi Michael^ORCID

Funder

Cutaneous Lymphoma Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference11 articles.

1. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal;Agar;J Clin Oncol,2010

2. Gentian violet is safe;Arbiser;J Am Acad Dermatol,2009

3. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation;Arulogun;Blood,2008

4. Drug combination studies and their synergy quantification using the Chou-talalay method;Chou;Cancer Res,2010

5. Treatment of recalcitrant mycosis fungoides with topical gentian violet;Cowan;JAAD Case Rep,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncovering the Potential of Phosphatidylinositol 3-Kinase Inhibitors in Cutaneous T-Cell Lymphoma: Insights from High-Throughput In Vitro Screenings;Journal of Investigative Dermatology;2022-01

2. Research Techniques Made Simple: Preclinical Development of Combination Antitumor Targeted Therapies in Dermatology;Journal of Investigative Dermatology;2020-12